Progenics Falls After Two Deaths in Prostate Cancer Drug Trial

... p.m. New York time, after losing as much as 20 percent for its biggest intraday drop since November 2012. The Tarrytown, New York-based company's stock had doubled in the 12 months through yesterday. The targeted chemotherapy treatment for prostate ...

http://ift.tt/1nmjCdo